Supplementary Table S1 from The Prognostic and Predictive Impact of ctDNA Levels in Patients with Advanced Breast Cancer Enrolled on the plasmaMATCH Trial

Iseult M. Browne; Javier Pascual; Rosalind J. Cutts; Belinda Kingston; Sarah Hrebien; Lucy Suzanne Kilburn; Alex Pearson; Laura J. Moretti; Andrew M. Wardley; Iain R. Macpherson; Richard D. Baird; Rebecca Roylance; Miguel Gil‐Gil; Ángel L. Guerrero-Zotano; Isaac García-Murillas; Judith M. Bliss; Alistair E. Ring; Miguel Martín; Nicholas C. Turner

doi:10.1158/1078-0432.31006810

Supplementary Table S1 from The Prognostic and Predictive Impact of ctDNA Levels in Patients with Advanced Breast Cancer Enrolled on the plasmaMATCH Trial

2026 Open access

Read full text

Authors: Iseult M. Browne, Javier Pascual, Rosalind J. Cutts, Belinda Kingston, Sarah Hrebien, Lucy Suzanne Kilburn, Alex Pearson, Laura J. Moretti, Andrew M. Wardley, Iain R. Macpherson, Richard D. Baird, Rebecca Roylance

+7 more

Miguel Gil‐Gil, Ángel L. Guerrero-Zotano, Isaac García-Murillas, Judith M. Bliss, Alistair E. Ring, Miguel Martín, Nicholas C. Turner

DOI: 10.1158/1078-0432.31006810

Cited by: 0

Abstract

List of the 74 genes included in the Guardant360 panel used for sequencing

Fields of Study & Subjects

Cancer Genomics and Diagnostics BRCA gene mutations in cancer Breast Cancer Treatment Studies

Publication details

Publication date: 6 January 2026